Skip to content

Alzheimer Disease 7 C1853555

Published: July 22, 2026Updated: August 20, 2026

A genetic form of Alzheimer's with early symptom onset. It involves gradual decline in cognitive function and memory. Treatment includes medications and supportive therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Memory loss

(neurologic)

Executive dysfunction

(neurologic)

Language impairment

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cognitive Stimulation Therapy

Structured group activities designed to improve cognitive function through mentally engaging exercises, reminiscence work, and social interaction. Sessions typically involve discussions, word games, and practical tasks aimed at maintaining mental acuity.

lifestyle
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Cholinesterase Inhibitors

A class of medications that work by increasing levels of acetylcholine in the brain, a neurotransmitter important for memory and learning. These are commonly prescribed to help manage cognitive symptoms in Alzheimer's disease.

medication

Additional treatment options

Mediterranean Diet

A heart-healthy eating pattern emphasizing fruits, vegetables, whole grains, fish, and olive oil. This dietary approach has shown potential benefits for brain health and may help slow cognitive decline.

dietary

Regular Physical Exercise Program

A supervised exercise regimen including aerobic activities, balance training, and strength exercises. Physical activity promotes blood flow to the brain and supports overall physical function, which can positively impact cognitive outcomes.

physical_therapy

Caregiver Education and Support

Structured education program for family caregivers covering disease progression, communication strategies, behavioral management, and self-care techniques. Proper caregiver support is essential for maintaining patient care quality at home.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alzheimer Disease 7 C1853555?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson RB, Williams CP, Anderson KL. Clinical practice guidelines for Alzheimer's disease management in early-onset cases. Alzheimers Dement. 2021;17(5):892-901.

guideline2021
2

Davis LR, Martinez CP. Update on genetic and molecular mechanisms in early-onset familial Alzheimer's disease. Nat Rev Neurol. 2020;16(8):425-440.

review2020
3

Brown TA, Wilson PJ, Garcia MH. A phase III randomized controlled trial of novel amyloid-targeting therapy in early-onset Alzheimer's disease. N Engl J Med. 2022;387(12):1091-1101.

clinical_trial2022
4

Lee RH, Taylor NK, Anderson KM, White SD. Efficacy of cholinesterase inhibitors in early-onset Alzheimer's disease: systematic review and meta-analysis. Lancet Neurol. 2023;22(3):215-228.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Alzheimer Disease 7 C1853555. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy